AspenBio Pharma (APPY)
|
2.33
-0.07 (-2.92%)
|
|
|
|
APPY additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
APPY Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Vanguard Extended Market Idx
Fidelity Spartan Extended Mkt Index Inv
iShares Russell 2000 Growth Index
iShares Russell Microcap Index
Aquila Rocky Mountain Equity A
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
T. Rowe Price Extended Equity Market Idx
Vanguard Balanced Index
iShares Russell 3000 Index
Fidelity Nasdaq Composite Index
Fidelity Spartan Extended Mkt Index Inv
iShares Russell 2000 Growth Index
iShares Russell Microcap Index
Aquila Rocky Mountain Equity A
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
T. Rowe Price Extended Equity Market Idx
Vanguard Balanced Index
iShares Russell 3000 Index
Fidelity Nasdaq Composite Index
•
Executives
Mr. Stephen T. Lundy
Chief Exec. Officer
Pres and Director
Mr. Jeffrey G. McGonegal
Chief Financial Officer
Principal Accounting Officer and Corp. Sec.
Dr. Michael Wandell r>Head of Regulatory and Clinical Affairs
N/AN/A Steve Tyrell r>Head of R&D
Mr. Donald R. Hurd
Chief Commercial Officer and Sr. VP
Chief Exec. Officer
Pres and Director
Mr. Jeffrey G. McGonegal
Chief Financial Officer
Principal Accounting Officer and Corp. Sec.
Dr. Michael Wandell r>Head of Regulatory and Clinical Affairs
N/AN/A Steve Tyrell r>Head of R&D
Mr. Donald R. Hurd
Chief Commercial Officer and Sr. VP
•
Employee Count
23
Special Offers
Competitors
APPY earnings
Date
Actual
Expected
Prev Yr Qtr
7/1/2008
-0.32
-0.38
-2.28
